	Quality Implementation of Lung Cancer Screening System (QUILSâ„¢ 1.0): A system to support high-quality delivery of lung cancer screening in diverse settings. Chest Studts JL, Knight JR, Yates AR, Alexander JL, Damron KJ, Barry AM, Studts CR, Brooks MT, Mullett TW. PMID: 41687809 [PubMed - as supplied by publisher]
	EVALUATION OF THE DEEP INSPIRATION BREATH-HOLD TECHNIQUE TO IMPROVE DOSIMETRIC OUTCOMES IN RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER. Georgian Med News Nabizade U, Isayev O, Haci G, Kazimov K, Nasirova G, Kaziyeva R, Guliyev E, Isayev I. PMID: 41687662 [PubMed - indexed for MEDLINE]
	A Randomized Phase II Trial of Hypo-fractionated Intensity-Modulated Radiation Therapy (IMRT) Utilizing 2.5 Gy/Fraction Versus Standard- Fractionated IMRT, Concurrent With Carboplatin/Paclitaxel and Followed by Consolidation Durvalumab, for Subjects With Stage III Non-Small Cell Lung Cancer. Clin Lung Cancer Reddy K, Wang F, Cao Y, Gan GN. PMID: 41687334 [PubMed - as supplied by publisher]
	Broadening clinical trial inclusivity of patients with lung cancer and brain metastases utilizing the Graded Prognostic Assessment (GPA): A call to action. Lung Cancer Alder L, Mullikin TC, Lascola C, Sperduto PW. PMID: 41687324 [PubMed - as supplied by publisher]
	Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancer. Cancer Treat Res Commun Azuma K, Osuga M, Itoh S, Kawa Y, Kozuki T, Toi Y, Murotani K, Izumi M, Murata D, Hata A, Sugawara S, Satouchi M, Yamamoto N, Koh Y. PMID: 41687194 [PubMed - as supplied by publisher]
	Medicaid Expansion and Stage at Diagnosis, Timely Initiation and Receipt of Guideline-Concordant Treatment, and Survival Among People With Non-Small Cell Lung Cancer. J Clin Oncol Zhao J, Graetz I, Howard D, Han X, Zhang L, Hu X, Yabroff KR, Lipscomb J. PMID: 41687045 [PubMed - as supplied by publisher]
	Prognostic nomogram for cancer-specific survival in adenosquamous carcinoma of lung patients treated with chemotherapy: A SEER-based retrospective cohort study. Medicine (Baltimore) Xiao J, Fan J, Wang M, Yuan X. PMID: 41686629 [PubMed - indexed for MEDLINE]
	Trajectory and predictive factors of cancer-related fatigue in hospitalized elderly patients with non-small cell lung cancer undergoing chemotherapy. Medicine (Baltimore) Liu C, Wang H, Wen J, Xu T, Wang H, Wei X, Zhai Y. PMID: 41686627 [PubMed - indexed for MEDLINE]
	Clinicopathological characteristics and prognosis of brain metastasis in non-small cell lung cancer: A retrospective study. Medicine (Baltimore) Fu X, Liu Q, Jia J, Wang M. PMID: 41686582 [PubMed - indexed for MEDLINE]
	Schizophyllum commune-associated allergic bronchopulmonary mycosis in a postoperative lung cancer patient: A case report and comprehensive literature review. Medicine (Baltimore) Wu N, Liang Y, Yan Q. PMID: 41686546 [PubMed - indexed for MEDLINE]
	Risk factors, clinical features, and impact on survival of lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective study. Medicine (Baltimore) Erten HÇ, Cömert S, Do, Fidan A, Geçmen GG, Özmen CA, Cengiz SK, Akku, Demirhan R. PMID: 41686545 [PubMed - indexed for MEDLINE]
	Exploring the unmet needs of older people living with lung cancer: a qualitative study. Age Ageing Knox N, Agar M, McErlean G, Vinod SK, Hickman L. PMID: 41686539 [PubMed - indexed for MEDLINE]
	Phase 1 Trial of Withania somnifera Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [(18)F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials. Integr Cancer Ther Heo JU, Rao S, Newton HB, Dowlati A, Muzic RF Jr, Kardan A. PMID: 41685666 [PubMed - indexed for MEDLINE]
	Research progress on long nonâ€‘coding RNAs in lung cancer (Review). Mol Med Rep Pan R, Wang C, Tang Y, Zhong F, Zhuang Y, Zhao Q. PMID: 41685590 [PubMed - indexed for MEDLINE]
	Timing and intensity of proton pump inhibitor exposure hampers overall survival in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors: a retrospective cohort study. Front Immunol Japelj N, Horvat N, Jazbar J, Kos M, Kapu, Knez L. PMID: 41685328 [PubMed - indexed for MEDLINE]
	Prognostic impact of advanced lung cancer inflammation index and tumor load index in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy. Front Immunol Huang Y, Chen M, Yang Z, Zhang Y, Lin C, Zhang S, Zeng T, Yu J, Chen C, Zheng B. PMID: 41685309 [PubMed - indexed for MEDLINE]
	Neoadjuvant immunotherapy for lung cancer: current limitations and future prospects. Front Immunol Yang K, Wang L, Wang Z, Lv P, Cai C, Zhao H, Sun W, Wang B. PMID: 41685302 [PubMed - indexed for MEDLINE]
	The predictive value of modified-Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy. Front Immunol Wang Y, Tang C, Bing J, Dejenie R, Zhang Y, Li F, Fang X, Chen X, Yang M, Zang Y, Li J. PMID: 41685299 [PubMed - indexed for MEDLINE]
	Usefulness of Novel Balloon-Less Convex Probe Bronchoscope for Diagnosing and Staging of Lung CancerÂ via EBUS-TBNA and EUS-B-FNA. Respirol Case Rep Takigawa Y, Sato K, Matsuoka S, Matsuo Y, Goda M, Shiraha K, Watanabe H, Nishimura J, Kudo K, Fujiwara K, Shibayama T. PMID: 41685178 [PubMed]
	Body Composition in Resectable Non-Small Cell Lung Cancer Patients With Preoperative Sarcopenia: A Propensity-Matched Analysis. J Cachexia Sarcopenia Muscle Wang ZZ, He JY, Tang RF, Zhang T, Luo L, Zhang YH, Zhang J, Lv XQ, Hong JF. PMID: 41684207 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 156382

Page 1 of 7820



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy